default author photo

Raphael Landovitz

University of California, Los Angeles (UCLA) - UCLA Center for Clinical AIDS Research and Education

11075 Santa Monica Blvd, Suite 100

Los Angeles, CA 90025

United States

  • University of California, Los Angeles (UCLA) - UCLA Center for Clinical AIDS Research and Education

SCHOLARLY PAPERS

3

DOWNLOADS

248

TOTAL CITATIONS

0

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Balancing Accuracy, Accessibility, and Cost: HIV Testing Strategies for Long-Acting Injectable Pre-Exposure Prophylaxis: A Systematic Review of Rapid, Laboratory-Based Immunoassay and Nucleic Acid Testing Strategies

Number of pages: 21 Posted: 04 Jun 2025
Warittha Tieosapjaroen, Eloise Williams, Cheryl Johnson, Carlota Almeida Baptista da Silva, Magdalena Barr-DiChiara, Michelle Rodolph, Heather Leigh Ingold, Heather-Marie Schmidt, Mateo Prochazka, Busisiwe Msimanga Radebe, Céline Lastrucci, Hortencia Peralta, Lastone Chitembo, Precious Andifasi, Nandi Siegfried, Raphael Landovitz and Jason J. Ong
Alfred Health - Melbourne Sexual Health Centre, University of Melbourne - Department of Microbiology, World Health Organization (WHO) - Global HIV, Hepatitis and STI Programme, Independent, World Health Organization (WHO) - Global HIV, Hepatitis and STI Programme, World Health Organization (WHO) - Global HIV, Hepatitis and STI Programme, World Health Organization (WHO) - Global HIV, Hepatitis and STI Programme, World Health Organization (WHO) - Global HIV, Hepatitis and STI Programme, World Health Organization (WHO) - Global HIV, Hepatitis and STI Programme, World Health Organization (WHO), World Health Organization (WHO) - Global HIV, Hepatitis and STI Programme, Pan American Health Organization, World Health Organization (WHO) - Global HIV, Hepatitis and STI Programme, World Health Organization (WHO) - Global HIV, Hepatitis and STI Programme, South African Medical Research Council - Health Systems Research Unit, University of California, Los Angeles (UCLA) - UCLA Center for Clinical AIDS Research and Education and Alfred Health
Downloads 125 (580,653)

Abstract:

Loading...

injectable pre-exposure prophylaxis, cabotegavir, lenacapavir, HIV testing, rapid diagnostic test, nucleic acid test, point-of-care test, HIV self-testing

2.

Estimating the Impact of PrEP Regimens Containing Long-Acting Injectable Cabotegravir or Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine Among Men Who Have Sex with Men in the United States: Mathematical Modelling for HPTN 083

Number of pages: 19 Posted: 26 May 2022
Kate M. Mitchell, Marie-Claude Boily, Brett Hanscom, Mia Moore, Jeffery Todd, Gabriela Paz-Bailey, Cyprian Wejnert, Albert Y. Liu, Deborah Donnell, Beatriz Grinsztejn, Raphael Landovitz and Dobromir Dimitrov
Imperial College London - Medical Research Council Centre for Global Infectious Disease Analysis, Imperial College London - Medical Research Council Centre for Global Infectious Disease Analysis, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Georgia Department of Public Health, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), San Francisco Department of Health - Bridge HIV, Fred Hutchinson Cancer Research Center, Oswaldo Cruz Foundation (FIOCRUZ) - Instituto Nacional de Infectologia Evandro Chagas (INIEC), University of California, Los Angeles (UCLA) - UCLA Center for Clinical AIDS Research and Education and Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division
Downloads 67 (899,324)

Abstract:

Loading...

HIV, pre-exposure prophylaxis, long-acting PrEP, injectable PrEP, cabotegravir, Men who have sex with men, MSM, United States, Atlanta, mathematical modelling

3.

Tail-Phase Safety, Tolerability, and Pharmacokinetics of Long-Acting Injectable Cabotegravir in HIV-Uninfected Adults: HPTN 077

Number of pages: 169 Posted: 05 Sep 2019
Raphael Landovitz, Sue Li, Joseph J. Eron Jr., Beatriz Grinsztejn, Halima Dawood, Albert Y. Liu, Manya Magnus, Mina C. Hosseinipour, Ravindre Panchia, Leslie Cottle, Gordon Chau, Paul Richardson, Mark A. Marzinke, Susan Eshleman, Ryan Kofron, Adeola Adeyeye, David Burns, Alex R. Rinehart, David Margolis, Myron S. Cohen, Marybeth McCauley and Craig W. Hendrix
University of California, Los Angeles (UCLA) - UCLA Center for Clinical AIDS Research and Education, Fred Hutchinson Cancer Research Center - Statistical Center for HIV/AIDS Research and Prevention, University of North Carolina (UNC) at Chapel Hill, Oswaldo Cruz Foundation (FIOCRUZ) - Evandro Chagas National Institute of Infectious Diseases (INI), University of KwaZulu-Natal - Centre for the AIDS Programme of Research in South Africa (CAPRISA), San Francisco Department of Health - Bridge HIV, George Washington University - Department of Epidemiology, University of North Carolina (UNC) at Chapel Hill - UNC-Project Malawi, Chris Hani Baragwanath Academic Hospital - Perinatal HIV Research Unit, Fred Hutchinson Cancer Research Center - Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center - Statistical Center for HIV/AIDS Research and Prevention, Johns Hopkins University - School of Medicine, Johns Hopkins University - School of Medicine, Johns Hopkins University - Department of Pathology, University of California, Los Angeles (UCLA) - UCLA Center for Clinical AIDS Research and Education, Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), Government of the United States of America - National Institutes of Health (NIH), ViiV Healthcare Ltd., ViiV Healthcare Ltd., University of North Carolina (UNC) at Chapel Hill, FHI 360 and Johns Hopkins University - School of Medicine
Downloads 56 (1,000,027)

Abstract:

Loading...

HIV Prevention, Cabotegravir, PrEP, Pre-Exposure Prophylaxis